<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:NCBITaxon="http://purl.obolibrary.org/obo/NCBITaxon#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:ncbitaxon="http://purl.obolibrary.org/obo/ncbitaxon#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                            NIH Public Access <br />                             Author Manuscript <br />                             Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                            Published final edited form as: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Basic Res Cardiol. 2013 September ; 108(5): 378. doi:10.1007/s00395-013-0378-5. <br />  <br />  <br />  <br />                            Stanniocalcin1 key mediator amyloidogenic light chain <br />                            induced cardiotoxicity <br />                            Jian Guan1,2, Shikha Mishra1, Jianru Shi1, Eva Plovie1, Yiling Qiu1, Xin Cao1, Davide <br />                            Gianni3, Bingbing Jiang1, Federica del Monte4, Lawreen H. Connors5, David C. Seldin5, <br />                            Francesca Lavatelli6, Paola Rognoni6, Giovanni Palladini6, Giampaolo Merlini6, Rodney H. <br />                            Falk7, Marc J. Semigran8, G. William Dec Jr.8, Calum A. MacRae1, Ronglih Liao1,7 <br />                            1Cardiovascular Division, Brigham Women&apos;s Hospital, Harvard Medical School, Boston, US <br />  <br />                            2Molecular    Medicine Graduate Program, Boston University School Medicine, Boston, US <br />                            3University   Massachusetts Medical School, Worcester, US <br />                            4Cardiovascular      Institute, Beth Israel Deaconess Medical Center, Boston, US <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                            5Amyloid    Research Treatment Program, Boston University School Medicine, Boston, US <br />                            6Amyloid    Research Treatment Center, University Pavia, Pavia, Italy <br />                            7Cardiac    Amyloidosis Program, Cardiovascular Division, Brigham Women&apos;s Hospital Boston, <br />                            US <br />                            8Harvard    Medical School, Boston MA Heart Center, Massachusetts General Hospital, Boston, US <br />  <br />                            Abstract <br />                                 Immunoglobulin light chain (LC) amyloidosis (AL) results overproduction circulating <br />                                 amyloidogenic LC proteins subsequent amyloid fibril deposition organs. Mortality AL <br />                                 amyloidosis patients highly associated rapidly progressive AL cardiomyopathy, marked <br />                                 profound impairment diastolic systolic cardiac function significant early mortality. <br />                                 While myocardial fibril deposition contributes severe diastolic dysfunction seen AL <br />                                 cardiomyopathy patients, degree fibril deposition correlate with <br />                                 prognosis. Previously, showed direct cardiotoxic effect amyloidogenic LC <br />                                 proteins (AL-LC), contribute pathophysiology mortality observed AL <br />                                 cardiomyopathy patients. However, mechanisms underlying AL-LC related cardiotoxicity <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                 remain unknown. Mammalian stanniocalcin1 (STC1) associated number cellular <br />                                 processes including oxidative stress cell death. Herein, STC1 expression is <br />                                 elevated cardiac tissue AL cardiomyopathy patients, induced isolated <br />                                 cardiomyocytes response AL-LC, non-amyloidogenic LC. STC1 overexpression in <br />                                 vitro recapitulates pathophysiology AL-LC mediated cardiotoxicity, increased ROS <br />                                 production, contractile dysfunction cell death. Overexpression STC1 vivo results in <br />                                 significant cardiac dysfunction cell death. Genetic silencing STC1 prevents AL-LC induced <br />                                 cardiotoxicity cardiomyocytes protects AL-LC induced cell death early <br />                                 mortality zebrafish. The cardiotoxic effects STC1 appears mediated mitochondrial <br />                                 dysfunction indicated loss mitochondrial membrane potential, ROS production and <br />  <br />  <br />  <br />  <br />                            Correspondence Dr. Ronglih Liao, Cardiac Muscle Research Laboratory, Cardiovascular Division, Brigham Women&apos;s Hospital, <br />                            Harvard Medical School, Boston, MA 02115, USA, rliao@rics.bwh.harvard.edu, Tele: 617-525-4864 (R.L.), Fax: 617-525-4868 <br />                            (R.L.). <br />                            Conflict Interest: The authors declare conflict interest. <br />                             Guan et al.                                                                                                   Page 2 <br />  <br />  <br />                                     increased mitochondrial calcium levels. Collectively, work identifies STC1 critical <br />                                     determinant AL-LC cardiotoxicity. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Keywords <br />                                     Amyloidosis; Cardiomyopathy; cardiac toxicity <br />  <br />                                               &#8216;Amyloidoses&#8217; represent group diseases characterized extracellular deposition of <br />                                               amyloid fibrils various tissues body [25]. Light chain (AL) amyloidosis most <br />                                               common systemic amyloidosis US Europe consequence plasma cell <br />                                               dyscrasia monoclonal overproduction amyloidogenic immunoglobulin light chain <br />                                               (LC) proteins associated deposition amyloid fibrils multiple tissues [26]. More <br />                                               half AL amyloidosis patients cardiac involvement, presenting rapidly <br />                                               progressive amyloid cardiomyopathy [10, 14]. Currently, limited therapies <br />                                               available AL amyloid cardiomyopathy, requiring cardiac transplantation, without <br />                                               median survival comparable malignant cancers [7]. Little is <br />                                               known regarding mechanisms underlie pathogenesis AL cardiomyopathy. <br />                                               Patients AL cardiomyopathy unresponsive traditional heart failure regimens <br />                                               suggesting distinct, unknown mechanisms contribute pathogenesis AL <br />                                               cardiomyopathy. Thus, great need uncover essential modulators AL <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               cardiomyopathy identify novel therapeutic targets. <br />  <br />                                               Interstitial amyloid fibril deposition heart long thought basis the <br />                                               pathogenesis AL cardiomyopathy. Clinical observations, however, suggested an <br />                                               important discrepancy survival cardiac amyloidosis patients similar degrees <br />                                               cardiac fibril infiltration, varying amyloid precursor proteins, suggesting alternative <br />                                               biological mechanisms disease progression. In addition, reduction circulating light <br />                                               chain levels, cardiac amyloid fibril deposition, associated improved patient <br />                                               outcomes [8]. The notion amyloid precursor proteins contribute disease pathology to <br />                                               equal extent amyloid fibril deposition suggested amyloid disease <br />                                               states [43]. Moreover, previous studies provided evidence direct, intrinsic <br />                                               cardiotoxic effect amyloidogenic light chain (AL-LC) proteins isolated <br />                                               cardiomyocytes intact mouse hearts, suggesting AL-LC cardiotoxicity may <br />                                               contribute cardiac dysfunction observed AL cardiomyopathy absence of <br />                                               fibril deposition [2, 24]. Our recent work implicated non-canonical TAB1 (TAK1 <br />                                               binding protein 1)-mediated p38MAPK autophosphorylation key modulator AL-LC <br />                                               cardiac toxicity [34]. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               Unbiased gene expression analysis human hearts explanted patients AL <br />                                               cardiomyopathy indicated increased differential expression Stanniocalcin1 (STC1) <br />                                               (personal communication, F. del Monte). STC1 originally identified corpuscles of <br />                                               Stannius fish secreted Ca2+ regulatory hormone [15] mammalian STC1 been <br />                                               associated number cellular processes including oxidative stress, inflammation, cell <br />                                               death impaired calcium homeostasis, implicated the <br />                                               pathogenesis AL-LC induced cardiotoxicity [20, 21, 30, 33]. We set to <br />                                               determine role STC1 pathophysiology AL-LC cardiotoxicity its <br />                                               potential relationship p38MAPK activation. <br />  <br />                                               Here, demonstrate upregulation STC1 heart tissue AL amyloid <br />                                               cardiomyopathy patients, isolated rat cardiomyocytes exposed human AL-LC <br />                                               proteins, p38MAPK dependent manner. STC1 provokes mitochondrial dysfunction <br />                                               leading excessive ROS production important mediating AL amyloid <br />  <br />  <br />                                                Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                           Page 3 <br />  <br />  <br />                                             cardiotoxicity cellular vivo models, overexpression STC1 <br />                                             recapitulating cellular dysfunction associated human AL-LC exposure vitro <br />                                             vivo. Moreover, genetic silencing STC1 protected AL-LC cardiotoxicity <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             early death cellular zebrafish models. <br />  <br />                               Methods <br />                               Human tissues <br />                                             All procedures related human tissue reviewed approved Institution <br />                                             Review Board (IRB) Boston University School Medicine Massachusetts General <br />                                             Hospital. Bence-Jones proteins, (AL-LC, amyloidogenic LC isolated AL amyloid <br />                                             patients Con-LC, non-amyloidogenic LC isolated non-amyloidosis multiple <br />                                             myeloma patients), purified urine collection collaboration Boston <br />                                             University Amyloid Treatment Research Program [5]. The purity fractionated LC <br />                                             proteins assessed SDS-PAGE immunoblotting described previously [2]. <br />                                             Additional information regarding human LC protein included Table S1. Human heart <br />                                             tissues collected explanted hearts patients AL amyloid cardiomyopathy at <br />                                             Massachusetts General Hospital. Non-disease control human hearts obtained from <br />                                             National Disease Research Interchange. Additional information regarding human <br />                                             samples included Table S2. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Animal care <br />                                             All animal (mouse, rat zebrafish) procedures usages reviewed approved <br />                                             Institutional Animal Care Use Committee Harvard Medical School. Animals <br />                                             housed Association Assessment Accreditation Laboratory Animal Care <br />                                             (AAALC) accredited animal care facilities 12 hour light-dark cycle fed <br />                                             laboratory chow ad libidum. Rats cardiomyocytes isolation purchased from <br />                                             Charles River Laboratory (male Wistar rats, 150-200g, catalog #003). Mice purchased <br />                                             Jackson Laboratory (female FVB/NJ/mice 10weeks catalog #001800). Wild type <br />                                             zebrafish purchased Ekkwill Waterlife Resources (Ruskin). Care breeding of <br />                                             zebrafish performed described previously [32, 41]. <br />  <br />                               Chemicals reagents <br />                                             General chemicals reagents obtained Sigma unless specified. Low glucose <br />                                             DMEM, TMRE, Rhod-2, Mitotracker-Green Laminin acquired Invitrogen. <br />                                             Mito-tempo Santa Cruz Biotechnology. Trypsin Collagenase purchased <br />                                             Willington. SB203580 compound obtained Calbiochem. Antibodies were <br />                                             obtained Santa Cruz Biotechnology (STC1, Bax, Bcl-2), Cell signaling <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Technology (p38MAPK phosphorylated p38MAPK), Sigma (ACTININ), R&amp;D Systems <br />                                             (STC1, GAPDH) Developmental Studies Hybridoma Bank (MF20). Secondary antibodies <br />                                             immunohistochemistry (Donkey anti-goat antibody-<span id='am-1' about='obo:NCBITaxon_149625' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_163739 obo:NCBITaxon_3814 obo:NCBITaxon_1 obo:NCBITaxon_72025 obo:NCBITaxon_131567 obo:NCBITaxon_3803 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_91827 obo:NCBITaxon_131221 obo:NCBITaxon_71240 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_91835 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_71275 obo:NCBITaxon_3193'><span id='am-2' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-4' property="rdfs:label" content="Alexa" datatype="xsd:string"></span><span id='am-5'  ></span>Alexa</span> Fluo 555, Goat anti-rabbit <br />                                             antibody- Alexa Fluo 488, Goat anti-mouse antibody- Alexa Fluo 647) from <br />                                             Invitrogen. Adenovirus expressing kit, adenovirus purification kit, STC1 recombinant <br />                                             protein purchased Stratagene, Adenopure, Biovendor, respectively. <br />  <br />                               Adenovirus preparation STC1 overexpression knockdown isolated <br />                               cardiomyocytes <br />                                             Full-length murine STC1 cDNA (Open Biosystems), subcloned pShuttle-IRES- <br />                                             GFP vector (Adeasy adenovirus system, Stratagene), later used generate adenovirus <br />                                             HEK cells according manufacturer&apos;s instruction. Control GFP adenovirus was <br />                                             generated using approach. To prepare STC1 shRNA adenovirus, expression <br />  <br />  <br />                                              Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                            Page 4 <br />  <br />  <br />                                           cassette containing shRNA cloning site, U6 promoter pCMV promoter driven GFP <br />                                           obtained pSicoR-GFP vector (Addgene) pShuttle vector. shRNA <br />                                           oligonucleotides (GATTC TCCCT CACAC ATCA) targeting STC1 designed using <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Invitrogen online software. The scrambled shRNA oligonucleotides (GACCC ACTAT <br />                                           CTAAC CTCT) STC1 shRNA designed using siRNA Wizard software <br />                                           (InvivoGen). Adenovirus purified Adenopure kit Puresyn Inc. <br />  <br />                               Cardiomyocytes isolation culture <br />                                           Adult rat ventricular cardiomyocytes isolated male Wistar rats using a <br />                                           collagenase-based enzymatic digestion method previously described [16]. <br />                                           Cardiomyocytes treated vehicle (ultrapure water), 20 &#956;g/mL Con-LC AL- <br />                                           LC designated time points described Results section. Neonatal rat <br />                                           cardiomyocytes isolated 1-2 day olds Wistar rats (Charles River Laboratory <br />                                           #003) previous described [13]. <br />  <br />                               Cell contractility intracellular Ca2+ measurements <br />                                           Cellular function Ca2+ homeostasis measured cultured adult ventricular <br />                                           cardiomyocytes using video edge detection fluorescence measurements calcium <br />                                           sensitive dye, Fura-2, respectively described previously [2]. Briefly, cardiomyocytes were <br />                                           infected Adeno-STC1 Adeno-GFP virus, treated vehicle, Con-LC or <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           AL-LC 24 hours. Cardiomyocytes perfused 1.2 mmol/L Ca2+ Tyrode&apos;s <br />                                           buffer 37&#176;C pacing 5 Hz. Percentage cellular shortening calculated the <br />                                           ratio difference systolic diastolic cell length diastolic cell length. <br />                                           Calcium amplitude calculated difference systolic diastolic cellular <br />                                           calcium levels (ratio F360/380). 4-6 cells measured biological replicate 3 <br />                                           biological replicates performed grouped statistical analysis. <br />  <br />                               Cell death assay <br />                                           At designed time points, cultured cardiomyocytes washed PBS, and <br />                                           immediately fixed 4% paraformaldehyde. Cells permeablized methanol at <br />                                           -20&#176;C 30 minutes, incubated TUNEL reaction mixture (Roche) moisture <br />                                           chamber hour 37&#176;C. Slides washed PBS, mounted mounting <br />                                           medium containing DAPI (Vectorlabs). For detection cell death zebrafish hearts, hearts <br />                                           dissected zebrafish Tyrode&apos;s solution containing 3% BSA. Hearts were <br />                                           transferred microwell plate fixed 4% paraformaldehyde 20 minutes. Hearts <br />                                           rinsed PBS permeablized overnight PBS 0.1% Tween. Following <br />                                           incubation anti- Myosin Heavy Chain (MF-20) antibody overnight 4&#176;C, hearts were <br />                                           washed 3 times PBS, followed incubation secondary antibody hour at <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           37&#176;C. Cell death detected using TUNEL reaction mixture (Roche) moisture <br />                                           chamber hour 37&#176;C. Hearts washed PBS placed directly into <br />                                           mounting media containing DAPI. For cells hearts, images taken with <br />                                           excitation wavelengths 405 nm 555 nm, 5-7 pictures taken slides <br />                                           using LSM700 confocal microscopy (Zeiss). Percent apoptotic cell death calculated <br />                                           TUNEL positive nuclei divided total nuclei. TUNEL positive nuclei manually <br />                                           counted total nuclei counted using Image J software (NIH). All counting <br />                                           performed blinded fashion. Caspase 3/7 activity determined freshly isolated <br />                                           homogenized extracts using Caspase 3/7 activity kits manufacturer&apos;s instructions <br />                                           (Promega, Caspase-Glo 3/7 Assay). Briefly, 30 &#956;g protein diluted final volume <br />                                           50 &#956;L PBS. 50 &#956;L Caspase 3/7 reaction buffer added protein sample, <br />                                           incubated 10 minutes dark, luciferase activity detected using plate <br />                                           reader (Spectra Max). <br />  <br />  <br />                                            Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                          Page 5 <br />  <br />  <br />                               RNA isolation quantitative PCR <br />                                           To assess gene expression, total RNA isolated using Trizol (Invitrogen) extraction. <br />                                           DNAase treatment performed subsequently remove residual DNA contamination <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           (Turbo DNAase, Ambion). iScript&#8482; cDNA Synthesis Kit (Bio-Rad) used first <br />                                           strand cDNA synthesis. Quantitative PCR performed using standard curve method. For <br />                                           human tissue, STC1 forward primer: ATTCCCACCAACAAAATCCA; reverse primer: <br />                                           GGAAAAACATGGCAGAGGAA. 18S forward primer: TCATGTGGTGTTGAGGAAGC; <br />                                           reverse primer: GGCGTGGATTCTGCATAATG. For rat tissue, STC1 forward primer: <br />                                           CACTTCCAGATATCCGCGTT; reverse primer: CACCTGGGGTCCTTCAGATA. <br />                                           GAPDH forward primer: GGTGATGCTGGTGCTGAGTA; reverse primer: <br />                                           TTGCTGACAATCTTGAGGGA. For fish tissue, STC1 forward primer: <br />                                           GTGCTTAAACAGTGCGCTC; reverse primer: GCTCCTGGGTTTGATTTGGC. EF1&#945; <br />                                           forward primer: CTGGAGGCCAGCTCAAACATGG; EF1&#945; reverse primer: <br />                                           ACTCGTGGTGCATCTCAACAGACT. <br />  <br />                               Immunohistochemistry staining <br />                                           Following cell isolation, adult cardiomyocytes cultured overnight fixed 4% <br />                                           paraformaldehyde room temperature. Cells permeabilized using 2% Triton-X100 in <br />                                           glycerol/PBS (1:1 volume). Incubation 3% BSA solution 1 hour performed to <br />                                           minimize non-specific binding. Cells incubated cocktail primary <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           antibodies (anti-STC1 [1:100], COX4 [1:1000] ACTININ [1:500]) 4&#176;C 18 hours <br />                                           followed incubating secondary antibodies steps 37&#176;C. First, donkey anti- <br />                                           goat Alexa Fluo 555 (1:300) used detect STC1. After 1xBPS wash out, goat anti- <br />                                           rabbit Alexa Fluo 488 (1:300) goat anti-mouse Alexa Fluo 647 (1:300) added <br />                                           1 hour 37&#176;C detect COX4 ACTININ, respectively. After final washing, the <br />                                           slides mounted VECTASHIELD&#174; mounting media (Vector Lab). Zeiss LSM700 <br />                                           fluorescence confocal microscope used visualize STC1 (Ex/Em: 550/600 nm), COX4 <br />                                           (Ex/Em: 488/525 nm), ACTININ (Ex/Em: 648/680). DAPI used stain the <br />                                           nuclei. <br />  <br />                               Immunoblotting analysis <br />                                           For cultured cardiomyocytes, protein harvested using cell lysis buffer (Cell Signaling). <br />                                           For mouse heart tissue, hearts pulverized liquid nitrogen resuspended cell <br />                                           lysis buffer. For zebrafish, 15-20 zebrafish suspended directly 50 &#956;L SDS loading <br />                                           buffer homogenized using tissue homogenizer (TissueLyser II, Qiagen). Following <br />                                           homogenization, samples centrifuged total protein homogenates obtained. <br />                                           30 &#956;g total protein 18 &#956;l fish protein lysate loaded Criterion XT bis-tris <br />                                           precast gels (4-12%) (Invitrogen) PAGEr Gold precast gels (4-20%) (Lonza) for <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           electrophoresis. Protein electrotransferred PVDF membrane (Millipore) 30 volts <br />                                           16-18 hours 4&#176;C. After blocking 5% BSA PBS, proteins detected <br />                                           incubation appropriate primary antibodies overnight 4&#176;C. After washing, blots <br />                                           incubated corresponding secondary antibodies. Odyssey infrared scanner (Li-Cor) <br />                                           used determine infrared fluorescent signal GAPDH used reference <br />                                           gene normalization. <br />  <br />                               Mitochondrial membrane potential measurement <br />                                           Following STC1 (200ng/mL) vehicle administration 24 hours, cultured <br />                                           cardiomyocytes incubated cell permeable, mitochondrial membrane potential- <br />                                           sensitive fluorophore TMRE (Invitrogen) concentration 10 nM 30 minutes. <br />                                           Cardiomyocytes washed warm PBS 2 times. TMRE fluorescence was <br />  <br />  <br />  <br />                                            Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                              Page 6 <br />  <br />  <br />                                           measured using SpectraMax M5 Microplate Reader (Molecular Device) excitation <br />                                           wavelength 555 nm. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Mitochondrial calcium measurement <br />                                           Following 24 hour exposure STC1 (200ng/mL) vehicle, cultured neonatal <br />                                           cardiomyocytes incubated cell permeable, mitochondrial specific calcium <br />                                           fluorophore Rhod-2 [6] (Invitrogen) concentration 40 &#956;M 30 minutes 37&#176;C. <br />                                           Rhod-2 reduced colorless dye using sodium borate. Hoechst dye (40 &#956;M) and <br />                                           Mitotracker Green (250 nM) used visualize nuclei mitochondria, <br />                                           respectively. Cardiomyocytes washed twice warm PBS. Cell images were <br />                                           acquired using LSM700 confocal microscopy. To specifically analyze mitochondrial <br />                                           calcium, Rhod-2 signal co-localized Mitotracker Green quantified. Analysis <br />                                           performed using Cell Profiler software. For biological replicate, 80-100 cells were <br />                                           analyzed condition. <span id='am-82' about='obo:NCBITaxon_1369087' typeof='obo:NCBITaxon_37567 owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_37570 obo:NCBITaxon_41191 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_41196 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_95182 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_7100 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-83' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-84' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-85'  ></span><span id='am-86' property="rdfs:label" content="Data" datatype="xsd:string"></span>Data</span> averaged total 3 biological replicates. <br />  <br />                               ROS measurement <br />                                           Following STC1 (200ng/mL) vehicle administration 24 hours, cultured <br />                                           cardiomyocytes incubated cell permeable, redox-sensitive fluorophore DCFDA <br />                                           (Invitrogen) concentration 20 &#956;M 30 minutes. Cardiomyocytes then <br />                                           washed warm PBS 2 times. Cell images acquired using LSM700 confocal <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           microscopy (excitation wavelength 488nm) analyzed SigmaScan Pro. For <br />                                           determination mitochondrial-derived ROS, Mitotempo (Santa Cruz Biotech), a <br />                                           mitochondrial specific ROS scavenger, used pre-treat cardiomyocytes the <br />                                           concentration 100 nM 45 minutes prior STC1 administration. <br />  <br />                               Assessment cardiac function zebrafish <br />                                           Individual fish embryos 3 4 dpf (days post fertilization) transiently anesthetized in <br />                                           Tricaine methanesulfonate (Sigma) solution E3 embryo water. Fish embryos were <br />                                           positioned laterally image acquisition [35]. Axioplan (Zeiss) upright microscopy <br />                                           equipped FastCam-PCI high-speed <span id='am-58' about='obo:NCBITaxon_274080' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_33154 obo:NCBITaxon_65171 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_7408 obo:NCBITaxon_7401 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_231877 obo:NCBITaxon_172377 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_7400 obo:NCBITaxon_33392 obo:NCBITaxon_7399 obo:NCBITaxon_50557'><span id='am-59' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-60'  ></span><span id='am-61' property="rdfs:label" content="Camera" datatype="xsd:string"></span><span id='am-62' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>camera</span> (Photron) used image acquisition. <br />                                           Sequential images heart contraction acquired 250 frames second. 8-10 cardiac <br />                                           cycles recorded fish. Long short axes diastole <span id='am-71' about='obo:NCBITaxon_1118718' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_75200 obo:NCBITaxon_246456 obo:NCBITaxon_33154 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6960 obo:NCBITaxon_6072 obo:NCBITaxon_33208 obo:NCBITaxon_7422 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_272201 obo:NCBITaxon_7400 obo:NCBITaxon_33392 obo:NCBITaxon_7399 obo:NCBITaxon_50557'><span id='am-72' property="rdfs:label" content="Systole" datatype="xsd:string"></span><span id='am-73'  ></span><span id='am-74' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-75' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>systole</span> were <br />                                           obtained using Image J (NIH) tracing cardiac cycles. Ventricular volume was <br />                                           calculated using equation Ventricular volume= (4/3) &#960; / s2 stroke volume were <br />                                           calculated based change diastole systole. 10-12 fish examined per <br />                                           condition. <br />  <br />                               Transient STC1 overexpression zebrafish model <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Plasmid containing length zebrafish STC1 purchased Open Biosystems <br />                                           (MDR1734-99237559). mMESSAGE mMACHINE Kit (Invitrogen) used synthesize <br />                                           zebrafish STC1 mRNA. STC1 mRNA reverse <span id='am-63' about='obo:NCBITaxon_order' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-64' property="rdfs:label" content="order" datatype="xsd:string"></span><span id='am-65' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>order</span> synthesized control. The <br />                                           quality/quantity mRNA determined Nanodrop spectrometer (Thermo Scientific). <br />                                           20 pg mRNA injected zebrafish embryos single cell stage. Cardiac function <br />                                           measured high-speed video camera 3 dpf (days post fertilization) cardiac cell <br />                                           death cardiac morphology determined 4dpf. <br />  <br />                               STC1 morpholino knockdown zebrafish model AL-LC cardiac toxicity <br />                                           Morpholinos (Gene-Tools, LLC) designed target boundary region exon <br />                                           2 intron 2 fish STC1 mRNA. Sequence used construct development was <br />                                           GCCTTGCCCTGTAAAATCAACAGAA. Morpholinos resuspended 1X Danieau&apos;s <br />                                           buffer (58 mmol/L NaCl, 0.7 mmol/L KCl, 0.4 mmol/L MgSO4, 0.6 mmol/L Ca(NO3)2, 0.5 <br />  <br />  <br />                                            Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                            Page 7 <br />  <br />  <br />                                            mmol/L Hepes, pH 7.6) achieve final concentration 500 &#956;mol/L. At single cell <br />                                            stage, 1 nL morpholino control (Danieau&apos;s buffer) solution injected. Veh (E3 <br />                                            water) AL-LC (1 nL 1 mg/mL) delivered circulation 2 dpf anaesthetized <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            control STC1 MO injected embryos venous injection described previously [29]. <br />                                            Cardiac function assessed using high-speed camera, described above, days post <br />                                            LC injections (4dpf). Three days following LC delivery (5dpf), protein expression cell <br />                                            death determined using immunoblotting STC1 TUNEL staining, respectively. <br />                                            In addition, zebrafish survival determined hearts embryos harvested for <br />                                            TUNEL staining immunoblotting, respectively. Zebrafish survival measured by <br />                                            counting zebrafish number STC1 MO control injected embryos immediately (2dpf) <br />                                            3 days (5dpf) following AL-LC vehicle injection percent survival was <br />                                            calculated accordingly. The percent survival averaged 5 independent repeats. <br />  <br />                               Statistical analysis <br />                                            All data shown mean &#177; standard error. Statistical differences mean values for <br />                                            groups evaluated Student t test using GraphPad Prism software. Statistical <br />                                            differences mean values multiple groups evaluated one-way analysis of <br />                                            variance. When comparisons significant, post-hoc Bonferroni&apos;s test used to <br />                                            compare individual groups. p&lt;0.05 considered significant. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Results <br />                               STC1 upregulated patients AL amyloid cardiomyopathy response to <br />                               human AL-LC <br />                                            To validate microarray gene profiling data (del Monte laboratory unpublished data), human <br />                                            heart samples (left ventricle) obtained AL amyloid cardiomyopathy patients <br />                                            (n=6) control patients heart disease (n=5) collected cold oxygenated Wisconsin <br />                                            cardioplegic solution immediately following harvest. STC1 mRNA expression was <br />                                            quantified using real-time PCR, upregulated hearts patients AL <br />                                            amyloid cardiomyopathy relative control non-failing heart samples (Fig. 1a). STC1 <br />                                            protein expression quantified immunoblotting analysis human heart samples, and <br />                                            similarly selectively upregulated patients AL amyloid cardiomyopathy <br />                                            (Fig. 1b). To determine STC1 expression induced AL-LC proteins absence <br />                                            fibril formation, adult rat ventricular cardiomyocytes exposed human AL- <br />                                            LC (20 &#956;g/mL), Con-LC (20 &#956;g/mL), vehicle control. AL-LC Con-LC vehicle, <br />                                            induced STC1 mRNA expression hour (Fig 1c), subsequent increases in <br />                                            STC1 protein expression early (2 hours) late (24 hours) time points (Fig 1d, e). <br />                                            Importantly, upregulation STC1 protein expression observed response AL-LC <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            proteins isolated 5 different AL amyloidosis patients (Fig. 1f). These data demonstrate <br />                                            STC1 expression specifically upregulated AL-LC proteins patients with <br />                                            AL amyloid cardiomyopathy isolated cardiomyocytes. <br />  <br />                               AL-LC induces STC1 upregulation p38MAPK dependent manner <br />                                            Previously, shown p38MAPK activation occurs minutes AL-LC <br />                                            exposure required AL-LC induced cardiotoxicity [34]. To determine whether <br />                                            p38MAPK regulates STC1 induction, isolated cardiomyocytes treated AL-LC, <br />                                            Con-LC, vehicle presence absence SB203580, selective p38MAPK inhibitor <br />                                            [34]. Inhibition p38MAPK completely prevented STC1 upregulation response AL- <br />                                            LC (Fig. 2a). In established mouse model AL-LC cardiotoxicity, generated by <br />                                            parenteral injection AL-LC proteins [34], human AL-LC induced cardiac STC1 protein <br />                                            expression mice, compared Con-LC treated mice (Fig. 2b). AL-LC induction cardiac <br />                                            STC1 expression, however, abolished transgenic mice cardiac expression of <br />  <br />                                             Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                          Page 8 <br />  <br />  <br />                                           dominant negative p38MAPK (DN-TG) (Fig. 2b). Collectively, vitro vivo <br />                                           data demonstrate AL-LC induction STC1 downstream p38MAPK activation, a <br />                                           necessary early signaling event upstream AL-LC induced cardiac toxicity. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               STC1 induces mitochondrial dysfunction provokes ROS generation <br />                                           To investigate function STC1 cardiomyocytes, sought delineate the <br />                                           cellular location STC1. Using immunohistochemical staining, STC1 is <br />                                           expressed nuclei mitochondria (Fig. 3a). Mitochondrial localization was <br />                                           confirmed co-staining STC1 mitochondrial protein, COX4, shown in <br />                                           Fig. 3b Fig. 3c. Given mitochondrial localization, examined STC1 <br />                                           alters mitochondrial function measuring mitochondrial membrane potential using the <br />                                           cell-permeable mitochondrial membrane potential-sensitive dye tetramethylrhodamine, ethyl <br />                                           ester (TMRE). Our data showed STC1 treatment significantly reduced mitochondrial <br />                                           membrane potential (Fig. 3d). Moreover, STC1 induced ROS production can <br />                                           attenuated pretreatment MitoTempo, mitochondrial specific ROS scavenger <br />                                           (Fig. 3e, f). To determine STC1 affects cardiomyocyte mitochondrial calcium <br />                                           levels, mitochondrial calcium concentration measured using mitochondrial calcium <br />                                           probe, Rhod2. We STC1 significantly elevates mitochondrial calcium levels (Fig <br />                                           3g, h), suggesting role STC1 dysregulation calcium homeostasis and <br />                                           mitochondrial function. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               STC1 recapitulates AL-LC cardiac pathology vitro vivo <br />                                           To define effects STC1 upregulation cardiomyocytes, STC1 overexpressed via <br />                                           adenoviral mediated gene transfer isolated adult rat cardiomyocytes. Expression STC1 <br />                                           (Adeno-STC1) control GFP (Adeno-GFP) titrated levels comparable that <br />                                           induced human AL-LC exposure, &#8764;1.5-2 fold increase (Fig. S1), avoid non-specific <br />                                           toxic effects associated excessive protein expression. STC1 overexpression decreased <br />                                           cell shortening (Fig 4a) diminished calcium transient amplitude (Fig 4b) concomitantly, <br />                                           measured single cardiomyocytes using video edge detection techniques a <br />                                           fluorescent calcium sensitive dye. Furthermore, STC1 overexpression increased cell death, <br />                                           assessed Bax/Bcl-2 ratio (Fig. 4c) quantification TUNEL positive cells (Fig. <br />                                           4d). In summary, STC1 overexpression caused cardiomyocyte dysfunction cell death, <br />                                           recapitulating AL-LC induced cardiac toxicity cardiomyocytes [34]. <br />  <br />                                           To determine STC1 adversely affects cardiac function cell viability vivo, <br />                                           STC1 transiently overexpressed zebrafish delivery STC1 mRNA one- <br />                                           cell stage development followed measurement cardiac function, TUNEL assay and <br />                                           morphological assessment illustrated Fig. 5a. The size purity mRNA was <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           confirmed showed Fig. S2a. STC1 mRNA (Fig. 5b) protein expression levels (Fig. <br />                                           5c) confirmed upregulated zebrafish 4dpf (4 days following STC1 mRNA <br />                                           injection). Equal protein loading confirmed Ponceau staining (Fig. S2b). Using <br />                                           high-speed camera imaging, reduction stroke volume (Fig. 5d) cardiac output (Fig. <br />                                           5e) observed early 3 days post STC1 mRNA injection (3dpf). No difference in <br />                                           heart rate STC1 overexpressing fish controls (Fig. 5f). Strikingly, <br />                                           STC1-overexpressing zebrafish displayed pericardial edema, characteristic landmark <br />                                           cardiac dysfunction zebrafish (Fig. 5g). Additionally, observed increased cardiac <br />                                           cell death cardiomyocytes STC1-overexpressing zebrafish compared controls, as <br />                                           assessed TUNEL cardiac marker (MF20) co-staining isolated hearts 4 dpf (Fig. <br />                                           5h, i). A similar increase cardiac cell death observed STC1-overexpressing <br />                                           zebrafish 5 dpf, compared controls (Fig. S3a, b). In accordance the <br />                                           phenotype observed STC1 overexpressing zebrafish, transient overexpression of <br />                                           STC1 mouse hearts vivo adenoviral-mediated gene transfer (Fig. S4a) resulted a <br />  <br />  <br />                                            Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                             Page 9 <br />  <br />  <br />                                           similar depression cardiac function (Fig. S4b). Additionally, cardiac cell death was <br />                                           increased STC1-overexpressing mouse hearts, assessed increased Bax/Bcl-2 ratio (Fig. <br />                                           S4c) caspase 3/7 activity (Fig. S4d). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               STC1 required AL-LC induced cardiac toxicity vitro vivo <br />                                           To determine STC1 plays causal role AL-LC induced cardiomyocyte <br />                                           dysfunction death, STC1 expression genetically silenced using adenoviral-mediated <br />                                           expression shRNA targeting STC1 (Adeno-STC1-shRNA) adult cardiomyocytes. <br />                                           Adeno-STC1-shRNA attenuated STC1 expression induced AL-LC adult <br />                                           cardiomyocytes compared scrambled controls (Fig. 6a), prevented AL-LC induced <br />                                           contractile dysfunction (Fig. 6b) impaired calcium homeostasis (Fig. 6c). AL-LC- <br />                                           induced cell death attenuated Adeno-STC1-shRNA treated cardiomyocytes (Fig. 6d). <br />                                           These data demonstrate requirement STC1 mediating AL-LC induced cellular <br />                                           dysfunction death. <br />  <br />                                           The necessity STC1 mediating AL-LC induced cardiac dysfunction mortality was <br />                                           examined vivo using zebrafish model AL-LC toxicity [29]. Consistent vitro <br />                                           experiments, injection human AL-LC induced STC1 expression (Fig. 7a). The time <br />                                           course morpholino injection various functional morphological readouts are <br />                                           outlined Fig. 7b. Similar vitro observations, AL-LC injection decreased cardiac <br />                                           function (Fig. 7c, d) increased cardiac cell death (Fig. 7e, f) increased <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           mortality (Fig. 7g), prevented STC1 morphants (Fig. 7c-g). It notable <br />                                           morpholino mediated knockdown successfully attenuated AL-LC induced STC1 <br />                                           upregulation entire time frame study showed Fig. 7h. Collectively, these <br />                                           results established STC1 critical mediator AL-LC induced cardiac pathology <br />                                           suggest antagonism STC1 serve novel therapeutic treatment approach. <br />  <br />                               Discussion <br />                                           While common forms cardiomyopathy, prevalence AL <br />                                           cardiomyopathy comparable Hodgkin&apos;s lymphoma chronic myelogenous <br />                                           leukemia [11]. Importantly, current statistics provide underestimation the <br />                                           prevalence AL cardiomyopathy under-diagnosis resulting insidious onset of <br />                                           disease, rapid progression, insufficient clinical awareness. Unlike forms of <br />                                           cardiomyopathy, AL amyloidosis cardiomyopathy largely unresponsive standard <br />                                           treatment regimens, resulting early mortality [10]. In study, provide critical <br />                                           molecular insight pathogenesis fatal disease identify STC1 key <br />                                           mediator AL-LC cardiotoxicity vitro vivo, highlighting potential of <br />                                           STC1 viable therapeutic target. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           It initially hypothesized AL amyloid cardiomyopathy direct result an <br />                                           infiltrative disease process associated extracellular deposition amyloid fibrils within <br />                                           heart coupled passive restriction cardiac function. However, clinical observations <br />                                           discordant proposed mechanism, little correlation degree of <br />                                           cardiac fibril infiltration cardiac dysfunction patients AL <br />                                           amyloid cardiomyopathy [8]. Instead, mortality correlate levels <br />                                           circulating LC [8]. Moreover, reduction circulating AL-LC shown a <br />                                           correlative improvement cardiac performance prolonged patient survival, despite the <br />                                           persistence cardiac amyloid deposits [31]. In line clinical observations, our <br />                                           laboratory subsequent independent confirmation [27, 28, 36] demonstrated <br />                                           direct cardiotoxic effect AL-LC proteins absence fibril formation, vitro <br />                                           vivo [2, 24, 34]. Thus, AL amyloidosis results intermingling pathogenic <br />                                           mechanisms involving amyloid fibril deposition direct cardiac toxicity AL-LC <br />  <br />                                            Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                          Page 10 <br />  <br />  <br />                                          precursor protein. The finding activation non-canonical p38MAPK pathway within <br />                                          minutes AL-LC exposure provided evidence acute induction specific <br />                                          AL-LC mediated signaling pathways heart [34]. In study, reveal STC1 a <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          novel downstream molecule AL-LC mediated p38MAPK activation. Importantly, we <br />                                          STC1 expression induced AL-LC proteins isolated separate AL <br />                                          patients, non-amyloidogenic Con-LC proteins multiple myeloma patients, <br />                                          suggesting observed STC1 upregulation potential artifact associated <br />                                          human AL-LC sample, generalizable AL amyloid <br />                                          cardiomyopathy. <br />  <br />                                          STC1 glycoprotein identified bony fish calcium regulatory hormone [38]. The <br />                                          mammalian STC1 homolog shares sequence homology fish counterpart, has <br />                                          implicated multitude cellular processes, including ischemic injury, apoptosis, <br />                                          angiogenesis, inflammation, <span id='am-20' about='obo:NCBITaxon_6754' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_72041 obo:NCBITaxon_33154 obo:NCBITaxon_6681 obo:NCBITaxon_6682 obo:NCBITaxon_6683 obo:NCBITaxon_29964 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_33208 obo:NCBITaxon_116706 obo:NCBITaxon_116704 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_6656 obo:NCBITaxon_6692 obo:NCBITaxon_1206794 obo:NCBITaxon_6657 obo:NCBITaxon_6753 obo:NCBITaxon_88770 obo:NCBITaxon_6752'><span id='am-21' property="rdfs:label" content="Cancer" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-24'  ></span>cancer</span> biology, bone muscle development, cellular <br />                                          metabolism, calcium regulation, differentiation endothelial permeability [4, 9, 12, 17, <br />                                          18, 20, 30, 33, 38-40, 42, 44, 45]. Numerous reports shown role STC1 a <br />                                          mediator apoptosis [20, 22, 42], demonstrating pro-apoptotic anti-apoptotic roles <br />                                          depending cell type stimulus. A recent report Nguyen et al suggested a <br />                                          pathologic role STC1 promoting apoptosis conditions oxidative stress [30]. <br />                                          Additionally, STC1 identified mediator apoptotic cell death in <br />                                          amyloidogenic A&#946; protein-treated endothelial cells radiated fibroblasts [1, 23]. Our <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          study suggests critical role STC1 extending localized amyloidosis, systemic <br />                                          amyloid diseases, specifically AL amyloid cardiomyopathy. Importantly, cardiac STC1 <br />                                          expression differentially increased patients AL amyloid cardiomyopathy not <br />                                          idiopathic dilated cardiomyopathy (del Monte Laboratory unpublished data). We able <br />                                          simulate increased STC1 observed AL cardiomyopathy patients fish, mouse and <br />                                          isolated rat cardiomyocytes, exposure human AL-LC, suggesting upregulation <br />                                          STC1 occurs cardiomyocyte autonomous process independent cardiac endothelial <br />                                          fibroblast cells (Fig. S5). Moreover, STC1 activation highly dependent upon <br />                                          p38MAPK activation, determined vitro pharmacologic inhibition vivo <br />                                          using mice overexpressing dominant negative p38MAPK. <br />  <br />                                          While profound diastolic dysfunction extensive amyloid fibril deposition a <br />                                          predominant manifestation AL cardiomyopathy, systolic dysfunction present. The <br />                                          degree systolic dysfunction actually underestimated using traditional <br />                                          echocardiographic parameters ejection fraction, recently detected using <br />                                          sensitive approaches including strain analysis [19]. In isolated cardiomyocytes, <br />                                          exposure AL-LC markedly decreases contractile dysfunction observed similar <br />                                          impairment systolic function vivo zebrafish exposed AL-LC, or <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          overexpressing STC1. <br />  <br />                                          Our report demonstrate pathological role cardiac STC1 AL-LC induced <br />                                          cardiac toxicity. The adverse effect STC1 heart consistent reports <br />                                          suggesting STC1 promotes cell death multiple cell types response diverse stress <br />                                          signals. STC1 act negative regulator fibroblast cell survival conditions of <br />                                          oxidative stress [30]. STC1 reported induced mRNA protein <br />                                          levels H2O2 furthermore, STC1 null mouse embryonic fibroblasts resistant to <br />                                          growth inhibition cell death induced H2O2 20% O2. Reintroduction STC1 into <br />                                          null mouse embryonic fibroblasts increases cell death conditions oxidative stress <br />                                          [30]. In contrast, cell types, neurons mesenchymal stem cells, STC1 has <br />                                          suggested exert protective functions [1, 45]. Our vivo data showing deleterious <br />                                          effects STC1 supported independent STC1 transgenic mouse studies which <br />                                          STC1 overexpression results decreased muscle mass deterioration muscle function <br />  <br />  <br />                                           Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                                        Page 11 <br />  <br />  <br />                                          [12, 37]. While STC1&apos;s role highly context dependent, genetic ablation STC1 mice <br />                                          associated little basal phenotype [3], highlighting potential of <br />                                          targeted STC1 antagonism therapeutic strategy. Our data STC1 mediated <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          mitochondrial damage, potentially calcium overload, resulting ROS production and <br />                                          loss mitochondrial integrity, underlying mechanism STC1-induced cardiac <br />                                          toxicity. Consistent findings, using cellular models STC1 transgenic mice, <br />                                          reports indicated STC1 directly targets mitochondria, causing profound <br />                                          dysfunction deformation mitochondria [9, 12]. Relevant finding, recent studies <br />                                          shown STC1 impair mitochondrial calcium homeostasis [9]. The observed <br />                                          increased mitochondria calcium response STC1 may, part, contribute decrease <br />                                          cytosolic calcium concentration. Altered cytosolic mitochondrial calcium levels may <br />                                          result impaired contractile function elevated ROS / mitochondrial dysfunction, <br />                                          respectively. Antagonizing STC1 resulted beneficial effects in vitro vivo, in <br />                                          isolated cardiomyocytes zebrafish, respectively. However, remains determined <br />                                          antagonizing STC1 alters natural progression amyloid cardiomyopathy in <br />                                          animal models, including involving chronic exposure AL-LC, as <br />                                          antagonizing STC1 viable option treatment amyloid cardiomyopathy <br />                                          patients. <br />  <br />                                          The current lack understanding molecular mechanisms underlying AL amyloid <br />                                          cardiomyopathy critical bottleneck development treatment diagnostics for <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          disease. The work presented represents efforts understanding the <br />                                          mechanisms underlying fatal disease demonstrate critical role STC1 <br />                                          mediating AL-LC induced proteotoxicity vitro vivo, studies both <br />                                          animal models patients, required definitively define pathophysiologic <br />                                          basis amyloid cardiomyopathy role STC1 process. <br />  <br />                               Supplementary Material <br />                                          Refer Web version PubMed Central supplementary material. <br />  <br />  <br />                               Acknowledgments <br />                                          The authors thank Ms. Wendy Du Carnegie Mellon University, Mr. Soeun Ngoy Brigham Women&apos;s <br />                                          Hospital (BWH) Cardiovascular Physiology Core, Ms. Gloria Chan Boston University (BU) Amyloidosis Center <br />                                          excellent technical assistances Drs. Yingyi Zhang, Judith Gwathmey Thomas E. Macgillivray for <br />                                          providing critical reagents. <span id='am-53' about='obo:NCBITaxon_169495' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_169440 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_7147 obo:NCBITaxon_43733 obo:NCBITaxon_33154 obo:NCBITaxon_43738 obo:NCBITaxon_480117 obo:NCBITaxon_33317 obo:NCBITaxon_169449 obo:NCBITaxon_480118 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_43750 obo:NCBITaxon_33208 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_7203 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_169455 obo:NCBITaxon_50557 obo:NCBITaxon_43741'><span id='am-54'  ></span><span id='am-55' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-56' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-57' property="rdfs:label" content="This" datatype="xsd:string"></span>This</span> work supported, part, National Institutes Health (NIH), <br />                                          HL088533, HL086967, HL093148, HL099073 (R.L.), DK90696 (D.C.S.), AG031804 (L.H.C.), American Heart <br />                                          Association (C.A.M.), Cardiac Amyloid Center, BWH (R.H.F., R.L.) Gruss Wildflower <br />                                          Foundations Amyloid Research Fund BU (L.H.C., D.C.S.). G.M. supported Associazione Italiana <br />                                          la Ricercasul Cancro Special Program 5x mille, Molecular Clinical Oncology. S.M. supported NIH T32 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          (T32HL007604). <br />  <br />  <br />                               References <br />                                          1. Block GJ, Ohkouchi S, Fung F, Frenkel J, Gregory C, Pochampally R, Dimattia G, Sullivan DE, <br />                                             Prockop DJ. Multipotent stromal cells activated reduce apoptosis upregulation and <br />                                             secretion stanniocalcin-1. Stem Cells. 2009; 27:670&#8211;681.10.1002/stem.20080742 [PubMed: <br />                                             19267325] <br />                                          2. Brenner DA, Jain M, Pimentel DR, Wang B, Connors LH, Skinner M, Apstein CS, Liao R. Human <br />                                             amyloidogenic light chains directly impair cardiomyocyte function increase cellular <br />                                             oxidant stress. Circ Res. 2004; 94:1008&#8211;1010.10.1161/01.RES.0000126569.75419.74 [PubMed: <br />                                             15044325] <br />  <br />  <br />  <br />  <br />                                           Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                                  Page 12 <br />  <br />  <br />                                          3. Chang AC, Cha J, Koentgen F, Reddel RR. The murine stanniocalcin 1 gene essential for <br />                                             growth development. Mol Cell Biol. 2005; 25:10604&#8211;10610.10.1128/MCB. <br />                                             25.23.10604-10610.2005 [PubMed: 16287871] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          4. Chang AC, Jellinek DA, Reddel RR. Mammalian stanniocalcins cancer. Endocr Relat Cancer. <br />                                             2003; 10:359&#8211;373.10.1677/erc.0.0100359 [PubMed: 14503913] <br />                                          5. Connors LH, Jiang Y, Budnik M, Theberge R, Prokaeva T, Bodi KL, Seldin DC, Costello CE, <br />                                             Skinner M. Heterogeneity primary structure, post-translational modifications, germline gene <br />                                             usage full-length amyloidogenic kappa1 immunoglobulin light chains. Biochemistry. 2007; <br />                                             46:14259&#8211;14271.10.1021/bi7013773 [PubMed: 18004879] <br />                                          6. Du J, Wang Y, Hunter R, Wei Y, Blumenthal R, Falke C, Khairova R, Zhou R, Yuan P, Machado- <br />                                             Vieira R, McEwen BS, Manji HK. Dynamic regulation mitochondrial function by <br />                                             glucocorticoids. Proc Natl Acad Sci U S A. 2009; 106:3543&#8211;3548.10.1073/pnas.0812671106 <br />                                             [PubMed: 19202080] <br />                                          7. Dubrey SW, Cha K, Anderson J, Chamarthi B, Reisinger J, Skinner M, Falk RH. The clinical <br />                                             features immunoglobulin light-chain (AL) amyloidosis heart involvement. QJM. 1998; <br />                                             91:141&#8211;157.10.1093/qjmed/91.2.141 [PubMed: 9578896] <br />                                          8. Dubrey SW, Cha K, Skinner M, LaValley M, Falk RH. Familial primary (AL) cardiac <br />                                             amyloidosis: echocardiographically similar diseases distinctly different clinical outcomes. <br />                                             Heart. 1997; 78:74&#8211;82.10.1136/hrt.78.1.74 [PubMed: 9290406] <br />                                          9. Ellard JP, McCudden CR, Tanega C, James KA, Ratkovic S, Staples JF, Wagner GF. The <br />                                             respiratory effects stanniocalcin-1 (STC-1) intact mitochondria cells: STC-1 uncouples <br />                                             oxidative phosphorylation actions modulated nucleotide triphosphates. Mol Cell <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Endocrinol. 2007; 264:90&#8211;101.10.1016/j.mce.2006.10.008 [PubMed: 17092635] <br />                                          10. Falk RH. Cardiac amyloidosis: treatable disease, overlooked. Circulation. 2011; 124:1079&#8211; <br />                                               1085.10.1161/CIRCULATIONAHA.110.010447 [PubMed: 21875922] <br />                                          11. Falk RH. Diagnosis management cardiac amyloidoses. Circulation. 2005; 112:2047&#8211; <br />                                               2060.10.1161/CIRCULATIONAHA.104.489187 [PubMed: 16186440] <br />                                          12. Filvaroff EH, Guillet S, Zlot C, Bao M, Ingle G, Steinmetz H, Hoeffel J, Bunting S, Ross J, Carano <br />                                               RA, Powell-Braxton L, Wagner GF, Eckert R, Gerritsen ME, French DM. Stanniocalcin 1 alters <br />                                               muscle bone structure function transgenic mice. Endocrinology. 2002; 143:3681&#8211; <br />                                               3690.10.1210/en.2001-211424 [PubMed: 12193584] <br />                                          13. Fisch S, Gray S, Heymans S, Haldar SM, Wang B, Pfister O, Cui L, Kumar A, Lin Z, Sen- <br />                                               Banerjee S, Das H, Petersen CA, Mende U, Burleigh BA, Zhu Y, Pinto YM, Liao R, Jain MK. <br />                                               Kruppel-like factor 15 regulator cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A. <br />                                               2007; 104:7074&#8211;7079.10.1073/pnas.0701981104 [PubMed: 17438289] <br />                                          14. Guan J, Mishra S, Falk RH, Liao R. Current perspectives cardiac amyloidosis. Am J Physiol <br />                                               Heart Circ Physiol. 2012; 302:H544&#8211;552.10.1152/ajpheart.00815.2011 [PubMed: 22058156] <br />                                          15. Ishibashi K, Imai M. Prospect stanniocalcin endocrine/paracrine mammals. Am J <br />                                               Physiol Renal Physiol. 2002; 282:F367&#8211;375.10.1152/ajprenal.00364.2000 [PubMed: 11832417] <br />                                          16. Jain M, Brenner DA, Cui L, Lim CC, Wang B, Pimentel DR, Koh S, Sawyer DB, Leopold JA, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               Handy DE, Loscalzo J, Apstein CS, Liao R. Glucose-6-phosphate dehydrogenase modulates <br />                                               cytosolic redox status contractile phenotype adult cardiomyocytes. Circ Res. 2003; 93:e9&#8211; <br />                                               16.10.1161/01.RES.0000083489.83704.76 [PubMed: 12829617] <br />                                          17. Kanellis J, Bick R, <span id='am-6' about='obo:NCBITaxon_316718' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_3646 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_235631 obo:NCBITaxon_3977 obo:NCBITaxon_91827 obo:NCBITaxon_131221 obo:NCBITaxon_71240 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_91835 obo:NCBITaxon_235892 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_71275 obo:NCBITaxon_3193'><span id='am-7' property="rdfs:label" content="Garcia" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-10'  ></span>Garcia</span> G, Truong L, Tsao CC, Etemadmoghadam D, Poindexter B, Feng L, <br />                                               Johnson RJ, Sheikh-Hamad D. Stanniocalcin-1, inhibitor macrophage chemotaxis and <br />                                               chemokinesis. Am J Physiol Renal Physiol. 2004; 286:F356&#8211;362.10.1152/ajprenal.00138.2003 <br />                                               [PubMed: 14570698] <br />                                          18. Koizumi K, Hoshiai M, Ishida H, Ohyama K, Sugiyama H, Naito A, Toda T, Nakazawa H, <br />                                               Nakazawa S. Stanniocalcin 1 prevents cytosolic Ca2+ overload cell hypercontracture in <br />                                               cardiomyocytes. Circ J. 2007; 71:796&#8211;801.10.1253/circj.71.796 [PubMed: 17457011] <br />                                          19. Koyama J, Falk RH. Prognostic significance strain Doppler imaging light-chain amyloidosis. <br />                                               JACC Cardiovasc Imaging. 2010; 3:333&#8211;342.10.1016/j.jcmg.2009.11.013 [PubMed: 20394893] <br />  <br />  <br />  <br />  <br />                                           Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                                Page 13 <br />  <br />  <br />                                          20. Lai KP, Law AY, Yeung HY, Lee LS, Wagner GF, Wong CK. Induction stanniocalcin-1 <br />                                              expression apoptotic human nasopharyngeal cancer cells p53. Biochem Biophys Res <br />                                              Commun. 2007; 356:968&#8211;975.10.1016/j.bbrc.2007.03.074 [PubMed: 17395153] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          21. Law AY, Ching LY, Lai KP, Wong CK. Identification characterization hypoxia- <br />                                              responsive element human stanniocalcin-1 gene. Mol Cell Endocrinol. 2010; 314:118&#8211; <br />                                              127.10.1016/j.mce.2009.07.007 [PubMed: 19628018] <br />                                          22. Law AY, Lai KP, Lui WC, Wan HT, Wong CK. Histone deacetylase inhibitor-induced cellular <br />                                              apoptosis involves stanniocalcin-1 activation. Exp Cell Res. 2008; 314:2975&#8211;2984.10.1016/ <br />                                              j.yexcr.2008.07.002 [PubMed: 18652825] <br />                                          23. Li K, Dong D, Yao L, Dai D, Gu X, Guo L. Identification STC1 <span id='am-11' about='obo:NCBITaxon_3554' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_3563 obo:NCBITaxon_91827 obo:NCBITaxon_71240 obo:NCBITaxon_131221 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_3524 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_3193'><span id='am-12' property="oboInOwl:hasRelatedSynonym" content="Beta L. 1753" datatype="xsd:string"></span><span id='am-13'  ></span><span id='am-14' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-16' property="rdfs:label" content="Beta" datatype="xsd:string"></span>beta</span>-amyloid activated <br />                                              gene human brain microvascular endothelial cells using cDNA microarray. Biochem Biophys <br />                                              Res Commun. 2008; 376:399&#8211;403.10.1016/j.bbrc.2008.08.158 [PubMed: 18786506] <br />                                          24. Liao R, Jain M, Teller P, Connors LH, Ngoy S, Skinner M, Falk RH, Apstein CS. Infusion light <br />                                              chains patients cardiac amyloidosis causes diastolic dysfunction isolated mouse <br />                                              hearts. Circulation. 2001; 104:1594&#8211;1597. [PubMed: 11581134] <br />                                          25. Merlini G, Bellotti V. Molecular mechanisms amyloidosis. N Engl J Med. 2003; 349:583&#8211; <br />                                              596.10.1056/NEJMra023144 [PubMed: 12904524] <br />                                          26. Merlini G, Seldin DC, Gertz MA. Amyloidosis: pathogenesis new therapeutic options. J Clin <br />                                              Oncol. 2011; 29:1924&#8211;1933.10.1200/JCO.2010.32.2271 [PubMed: 21483018] <br />                                          27. Migrino RQ, Hari P, Gutterman DD, Bright M, Truran S, Schlundt B, Phillips SA. Systemic and <br />                                              microvascular oxidative stress induced light chain amyloidosis. Int J Cardiol. 2010; 145:67&#8211; <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              68.10.1016/j.ijcard.2009.04.044 [PubMed: 19446898] <br />                                          28. Migrino RQ, Truran S, Gutterman DD, Franco DA, Bright M, Schlundt B, Timmons M, Motta A, <br />                                              Phillips SA, Hari P. Human microvascular dysfunction apoptotic injury induced AL <br />                                              amyloidosis light chain proteins. Am J Physiol Heart Circ Physiol. 2011; 301:H2305&#8211; <br />                                              2312.10.1152/ajpheart.00503.2011 [PubMed: 21963839] <br />                                          29. Mishra S, Guan J, Plovie E, Seldin DC, Connors LH, Merlini G, Falk RH, Macrae CA, Liao R. <br />                                              Human amyloidogenic light chain proteins result cardiac dysfunction, cell death early <br />                                              mortality zebrafish. Am J Physiol Heart Circ Physiol. 2013; 305:H95&#8211;H103.10.1152/ajpheart. <br />                                              00186.2013 [PubMed: 23624626] <br />                                          30. Nguyen A, Chang AC, Reddel RR. Stanniocalcin-1 acts negative feedback loop the <br />                                              prosurvival ERK1/2 signaling pathway oxidative stress. Oncogene. 2009; 28:1982&#8211; <br />                                              1992.10.1038/onc.2009.65 [PubMed: 19347030] <br />                                          31. Palladini G, Lavatelli F, Russo P, Perlini S, Perfetti V, Bosoni T, Obici L, Bradwell AR, D&apos;Eril <br />                                              GM, Fogari R, Moratti R, Merlini G. Circulating amyloidogenic free light chains serum N- <br />                                              terminal natriuretic peptide type B decrease simultaneously association improvement of <br />                                              survival AL. Blood. 2006; 107:3854&#8211;3858.10.1182/blood-2005-11-4385 [PubMed: 16434487] <br />                                          32. Panakova D, Werdich <span id='am-76' about='obo:NCBITaxon_152839' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_4447 obo:NCBITaxon_4747 obo:NCBITaxon_158359 obo:NCBITaxon_158331 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_158350 obo:NCBITaxon_73496 obo:NCBITaxon_131221 obo:NCBITaxon_58024 obo:NCBITaxon_58023 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_1437197 obo:NCBITaxon_3193'><span id='am-77' property="oboInOwl:hasRelatedSynonym" content="Aa Rchb.f." datatype="xsd:string"></span><span id='am-78' property="rdfs:label" content="Aa" datatype="xsd:string"></span><span id='am-79' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-80' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-81'  ></span>AA</span>, Macrae CA. Wnt11 patterns myocardial electrical gradient through <br />                                              regulation L-type Ca(2+) channel. Nature. 2010; 466:874&#8211;878.10.1038/nature09249 <br />                                              [PubMed: 20657579] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          33. Sheikh-Hamad D, Bick R, Wu GY, Christensen BM, Razeghi P, Poindexter B, Taegtmeyer H, <br />                                              Wamsley A, <span id='am-66' about='obo:NCBITaxon_267975' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_1329799 obo:NCBITaxon_1 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_32524 obo:NCBITaxon_436489 obo:NCBITaxon_117570 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_9126 obo:NCBITaxon_33154 obo:NCBITaxon_8782 obo:NCBITaxon_436486 obo:NCBITaxon_1338369 obo:NCBITaxon_8287 obo:NCBITaxon_2759 obo:NCBITaxon_8492 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_8825 obo:NCBITaxon_7776 obo:NCBITaxon_436492 obo:NCBITaxon_175121 obo:NCBITaxon_32561 obo:NCBITaxon_9158 obo:NCBITaxon_8457 obo:NCBITaxon_436491'><span id='am-67' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-68' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-69'  ></span><span id='am-70' property="rdfs:label" content="Padda" datatype="xsd:string"></span>Padda</span> R, Entman M, Nielsen S, Youker K. Stanniocalcin-1 naturally occurring L- <br />                                              channel inhibitor cardiomyocytes: relevance human heart failure. Am J Physiol Heart Circ <br />                                              Physiol. 2003; 285:H442&#8211;448.10.1152/ajpheart.01071.2002 [PubMed: 12663264] <br />                                          34. Shi J, Guan J, Jiang B, Brenner DA, Del Monte F, Ward JE, Connors LH, Sawyer DB, Semigran <br />                                              MJ, Macgillivray TE, Seldin DC, Falk R, Liao R. Amyloidogenic light chains induce <br />                                              cardiomyocyte contractile dysfunction apoptosis non-canonical p38alpha MAPK <br />                                              pathway. Proc Natl Acad Sci U S A. 2010; 107:4188&#8211;4193.10.1073/pnas.0912263107 [PubMed: <br />                                              20150510] <br />                                          35. Shin JT, Pomerantsev EV, Mably JD, MacRae CA. High-resolution cardiovascular function <br />                                              confirms functional orthology myocardial contractility pathways zebrafish. Physiol <br />                                              Genomics. 2010; 42:300&#8211;309.10.1152/physiolgenomics.00206.2009 [PubMed: 20388839] <br />                                          36. Sikkink LA, Ramirez-Alvarado M. Cytotoxicity amyloidogenic immunoglobulin light chains in <br />                                              cell culture. Cell Death Dis. 2010; 1:e98.10.1038/cddis.2010.75 [PubMed: 21368874] <br />  <br />  <br />  <br />                                           Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                                  Page 14 <br />  <br />  <br />                                          37. Varghese R, Gagliardi AD, Bialek PE, Yee SP, Wagner GF, Dimattia GE. Overexpression of <br />                                              human stanniocalcin affects growth reproduction transgenic mice. Endocrinology. 2002; <br />                                              143:868&#8211;876.10.1210/en.143.3.868 [PubMed: 11861508] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          38. Wagner GF, Dimattia GE. The stanniocalcin <span id='am-17' about='obo:NCBITaxon_family' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-18' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-19' property="rdfs:label" content="family" datatype="xsd:string"></span>family</span> proteins. J Exp Zoolog A Comp Exp Biol. <br />                                              2006; 305:769&#8211;780.10.1002/jez.a.313 <br />                                          39. Wang Y, Huang L, Abdelrahim M, Cai Q, Truong A, Bick R, Poindexter B, Sheikh-Hamad D. <br />                                              Stanniocalcin-1 suppresses superoxide generation macrophages induction of <br />                                              mitochondrial UCP2. J Leukoc Biol. 2009; 86:981&#8211;988.10.1189/jlb.0708454 [PubMed: 19602668] <br />                                          40. Westberg JA, Serlachius M, Lankila P, Penkowa M, Hidalgo J, Andersson LC. Hypoxic <br />                                              preconditioning induces neuroprotective stanniocalcin-1 brain IL-6 signaling. Stroke. 2007; <br />                                              38:1025&#8211;1030.10.1161/01.STR.0000258113.67252.fa [PubMed: 17272771] <br />                                          41. Westerfield, M. The zebrafish book. A guide laboratory use zebrafish (<span id='am-25' about='obo:NCBITaxon_7955' typeof='owl:Thing obo:NCBITaxon_186623 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_186627 obo:NCBITaxon_186626 obo:NCBITaxon_131567 obo:NCBITaxon_186625 obo:NCBITaxon_117570 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_33154 obo:NCBITaxon_7952 obo:NCBITaxon_7954 obo:NCBITaxon_7953 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_32519 obo:NCBITaxon_30727 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_186634 obo:NCBITaxon_1489341 obo:NCBITaxon_7776 obo:NCBITaxon_7898 obo:NCBITaxon_41665 obo:NCBITaxon_32443'><span id='am-26' property="oboInOwl:hasExactSynonym" content="zebra fish" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasRelatedSynonym" content="Danio frankei" datatype="xsd:string"></span><span id='am-28'  ></span><span id='am-29' property="oboInOwl:hasRelatedSynonym" content="Danio rerio frankei" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasRelatedSynonym" content="Cyprinus rerio" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:hasExactSynonym" content="leopard danio" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasRelatedSynonym" content="Brachidanio rerio" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:hasExactSynonym" content="zebra danio" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:hasRelatedSynonym" content="Brachydanio rerio frankei" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasAlternativeId" content="NCBITaxon:27702" datatype="xsd:string"></span><span id='am-37' property="oboInOwl:hasRelatedSynonym" content="Cyprinus rerio Hamilton, 1822" datatype="xsd:string"></span><span id='am-38' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-39' property="oboInOwl:hasRelatedSynonym" content="Brachydanio rerio" datatype="xsd:string"></span><span id='am-40' property="rdfs:label" content="Danio rerio" datatype="xsd:string"></span><span id='am-41' property="oboInOwl:hasRelatedSynonym" content="Danio rerio (Hamilton, 1822)" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:hasExactSynonym" content="zebrafish" datatype="xsd:string"></span><span id='am-43' property="oboInOwl:hasAlternativeId" content="NCBITaxon:37966" datatype="xsd:string"></span>Danio rerio</span>). <br />                                              University Oregon Press; Eugene: 2000. <br />                                          42. Wu S, Yoshiko Y, De Luca F. Stanniocalcin 1 acts paracrine regulator growth plate <br />                                              chondrogenesis. J Biol Chem. 2006; 281:5120&#8211;5127.10.1074/jbc.M506667200 [PubMed: <br />                                              16377640] <br />                                          43. Yankner BA, Lu T. Amyloid beta-protein toxicity pathogenesis Alzheimer disease. J <br />                                              Biol Chem. 2009; 284:4755&#8211;4759.10.1074/jbc.R800018200 [PubMed: 18957434] <br />                                          44. Yeung HY, Lai KP, Chan HY, Mak NK, Wagner GF, Wong CK. Hypoxia-inducible factor-1- <br />                                              mediated activation stanniocalcin-1 human cancer cells. Endocrinology. 2005; 146:4951&#8211; <br />                                              4960.10.1210/en.2005-0365 [PubMed: 16109785] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          45. Zhang K, Lindsberg PJ, Tatlisumak T, Kaste M, Olsen HS, Andersson LC. Stanniocalcin: A <br />                                              molecular guard neurons cerebral ischemia. Proc Natl Acad Sci U S A. 2000; 97:3637&#8211; <br />                                              3642.10.1073/pnas.070045897 [PubMed: 10725397] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                        Page 15 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Fig. 1. <br />                                          STC1 upregulated patients AL cardiomyopathy response AL-LC <br />                                          stimulation. STC1 gene expression (normalized 18S) b STC1 protein expression <br />                                          relative GAPDH upregulated AL cardiomyopathy patients (N=6) compared to <br />                                          non-failing control patients (N=5). AL-LC triggers c STC1 gene d, e protein expression <br />                                          isolated cardiomyocytes exposed AL-LC 2 hour 24 hours, respectively, relative <br />                                          exposed Con-LC Veh. f STC1 upregulated early AL-LC obtained <br />                                          5 independent patients amyloid cardiomyopathy compared Veh Con-LC. <br />                                          * p&lt;0.05 indicated groups. <br />  <br />  <br />  <br />                                           Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                      Page 16 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Fig. 2. <br />                                          AL-LC induction STC1 p38MAPK dependent vitro vivo. AL-LC induced <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          upregulation STC1 protein expression cardiomyocytes abolished presence of <br />                                          p38MAPK inhibitor, SB203580 (5 &#956;mol/L). b AL-LC triggered upregulation cardiac <br />                                          STC1 protein expression prevented p38MAPK dominate negative (DN-TG) mice. * <br />                                          p&lt;0.05, AL-LC vs. vehicle Con-LC, # p&lt;0.05 AL-LC vs. SB203580 AL- <br />                                          LC infused wild type mice vs. DN-TG mice. N=3 group. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                      Page 17 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Fig. 3. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          STC1 affects mitochondrial calcium homeostasis function. Subcellular localization of <br />                                          STC1 cardiomyocytes determined using immunohistochemical staining DAPI <br />                                          (blue), STC1 (red), mitochondrial COX4 (green), myofilament protein, ACTININ <br />                                          (white). b Merged images immunohistochemical staining indicates STC1 co- <br />                                          localized mitochondria nucleus. c Line scanning analysis demonstrates close <br />                                          overlap spectral profiles red fluorophore (STC1) green fluorophore (COX4), <br />                                          confirming mitochondrial localization STC1. d Mitochondrial membrane potential is <br />                                          decreased cardiomyocytes exposed 200 ng/mL STC1 24 hours determined by <br />                                          TMRE, mitochondrial membrane potential sensitive fluorescence dye. e AL-LC induced <br />                                          ROS prevented cardiomyocytes treated mitochondrial targeted ROS <br />                                          scavenger, MitoTempo. f Representative DCFDA fluorescence images corresponding <br />                                          bright field images right. g Representative fluorescent images Rhod2 (red) and <br />                                          mitotracker (green), suggesting increased mitochondrial calcium response 200 ng/mL <br />  <br />  <br />                                           Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                         Page 18 <br />  <br />  <br />                                          STC1 stimulation 24 hours. h Summarized data mitochondrial calcium levels. * <br />                                          p&lt;0.05 indicated groups. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                         Page 19 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Fig. 4. <br />                                  <br /> </body></html>